Natixis Sells 78,307 Shares of The Allstate Co. (NYSE:ALL)

Natixis trimmed its holdings in shares of The Allstate Co. (NYSE:ALL) by 21.3% in the second quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 289,454 shares of the insurance provider’s stock after selling 78,307 shares during the quarter. Natixis owned 0.10% of The Allstate worth $37,756,000 as of its most recent filing with the SEC.

Several other institutional investors and hedge funds have also modified their holdings of the company. Andesa Financial Management Inc. grew its stake in shares of The Allstate by 2.9% during the 2nd quarter. Andesa Financial Management Inc. now owns 2,654 shares of the insurance provider’s stock worth $344,000 after acquiring an additional 76 shares in the last quarter. Avantax Planning Partners Inc. grew its stake in shares of The Allstate by 2.8% during the 2nd quarter. Avantax Planning Partners Inc. now owns 2,951 shares of the insurance provider’s stock worth $385,000 after acquiring an additional 81 shares in the last quarter. Providence Wealth Advisors LLC grew its stake in shares of The Allstate by 0.5% in the second quarter. Providence Wealth Advisors LLC now owns 16,545 shares of the insurance provider’s stock valued at $2,193,000 after buying an additional 84 shares in the last quarter. Banco Bilbao Vizcaya Argentaria S.A. grew its stake in shares of The Allstate by 1.2% in the first quarter. Banco Bilbao Vizcaya Argentaria S.A. now owns 7,405 shares of the insurance provider’s stock valued at $851,000 after buying an additional 85 shares in the last quarter. Finally, Intersect Capital LLC grew its stake in shares of The Allstate by 3.1% in the second quarter. Intersect Capital LLC now owns 2,933 shares of the insurance provider’s stock valued at $383,000 after buying an additional 88 shares in the last quarter. 75.00% of the stock is owned by institutional investors.

NYSE:ALL traded down $1.08 during mid-day trading on Thursday, reaching $125.73. The stock had a trading volume of 3,367 shares, compared to its average volume of 1,776,641. The stock has a 50-day simple moving average of $131.92 and a two-hundred day simple moving average of $130.14. The stock has a market capitalization of $37.18 billion, a PE ratio of 9.91, a P/E/G ratio of 1.09 and a beta of 0.86. The company has a debt-to-equity ratio of 0.31, a current ratio of 0.45 and a quick ratio of 0.45. The Allstate Co. has a 12 month low of $86.51 and a 12 month high of $140.00.

The Allstate (NYSE:ALL) last announced its quarterly earnings data on Tuesday, August 3rd. The insurance provider reported $3.79 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $3.17 by $0.62. The business had revenue of $10.44 billion for the quarter, compared to analysts’ expectations of $10.57 billion. The Allstate had a net margin of 8.27% and a return on equity of 22.27%. The firm’s quarterly revenue was up 13.2% compared to the same quarter last year. During the same period last year, the firm posted $2.46 earnings per share. Equities analysts expect that The Allstate Co. will post 16.02 EPS for the current year.

The Allstate announced that its Board of Directors has authorized a share repurchase plan on Wednesday, August 4th that authorizes the company to repurchase $5.00 billion in outstanding shares. This repurchase authorization authorizes the insurance provider to buy up to 13% of its stock through open market purchases. Stock repurchase plans are usually a sign that the company’s board of directors believes its stock is undervalued.

Several equities research analysts have issued reports on the company. Wells Fargo & Company raised their price target on The Allstate from $125.00 to $135.00 and gave the company an “equal weight” rating in a report on Friday, July 9th. Raymond James reaffirmed a “buy” rating and set a $150.00 price target on shares of The Allstate in a report on Friday, September 17th. UBS Group raised their price target on The Allstate from $118.00 to $139.00 and gave the company a “neutral” rating in a report on Friday, July 9th. Barclays raised their price target on The Allstate from $144.00 to $147.00 and gave the company an “overweight” rating in a report on Friday, August 6th. Finally, Wolfe Research assumed coverage on The Allstate in a report on Monday, August 16th. They set a “peer perform” rating and a $130.00 price target for the company. Eight investment analysts have rated the stock with a hold rating and seven have issued a buy rating to the company’s stock. According to data from MarketBeat, the stock has a consensus rating of “Hold” and a consensus price target of $140.62.

The Allstate Profile

The Allstate Corp. engages in the property and casualty insurance business and the sale of life, accident, and health insurance products through its subsidiaries. It operates through following business segments: Allstate Protection, Protection Services, Allstate Life, Allstate Benefits, Allstate Annuities, Discontinued Lines and Coverages, and Corporate and Other.

Recommended Story: Stocks Increasing Dividends

Institutional Ownership by Quarter for The Allstate (NYSE:ALL)

Receive News & Ratings for The Allstate Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for The Allstate and related companies with MarketBeat.com's FREE daily email newsletter.